Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Neurovia

Neurovia?uq=x1rNslWr
2013 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$13.9M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of therapies designed to offer treatment for neurological disorders. The company's therapies has developed a selective thyromimetic agent for the treatment of X-linked adrenoleukodystrophy (X-ALD), enabling X-ALD patients to get treatment for their rare genetic disease.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 332 Broadway
  • Unit 1
  • Cambridge, MA 02139
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Neurovia’s full profile, request a free trial.

Neurovia Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 25-May-2017 $13.9M 000.00 000.00 Completed Clinical Trials - Phase 1
To view this company’s complete deal history including valuation and funding, request access »

Neurovia Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Neurovia Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Biobrit Venture Capital Minority 000 0000 000000 0
BioMed Ventures Corporate Venture Capital Minority 000 0000 000000 0
Enso Ventures Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Sanofi-Genzyme Bioventures Corporate Venture Capital Minority 000 0000 000000 0

Neurovia Executive Team (4)

Name Title Board
Seat
Contact
Info
Giovanni Ferrara Co-Founder, President, Chief Executive Officer & Board Member
John Henderson MD Chief Development Officer
Thomas Scanlan Ph.D Founder & Chairman of Scientific Advisory Board
Masoud Mokhtarani MD Chief Medical Officer

Neurovia Board Members (4)

Name Representing Role Since Contact
Info
Giovanni Ferrara Neurovia Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Henry Skinner Ph.D Novartis Venture Fund Board Member 000 0000
Jason Hafler Ph.D Sanofi-Genzyme Bioventures Board Member 000 0000
Thomas Scanlan Ph.D Neurovia Founder & Chairman of Scientific Advisory Board 000 0000